EyePoint Pharmaceuticals (NASDAQ:EYPT – Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.61) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.41 by ($1.02), reports. EyePoint Pharmaceuticals had a negative net margin of 283.81% and a negative return on equity of 82.21%. The company had revenue […]